The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico
Open accessAbstract
Background: The SARS-CoV-2 outbreak poses a challenge to health care systems due to its high complication rates in patients with cardiometabolic diseases. Here, we identify risk factors and propose a clinical score to predict COVID-19 lethality, including specific factors for diabetes and obesity, and its role in improving risk prediction. Methods: We obtained data of confirmed and negative COVID-19 cases and their demographic and health characteristics from the General Directorate of Epidemiology of the Mexican Ministry of Health. We investigated specific risk factors associated to COVID-19 positivity and mortality and explored the impact of diabetes and obesity on modifying COVID-19-related lethality. Finally, we built a clinical score to predict COVID-19 lethality. Results: Among the 177 133 subjects at the time of writing this report (May 18, 2020), we observed 51 633 subjects with SARS-CoV-2 and 5,332 deaths. Risk factors for lethality in COVID-19 include early-onset diabetes, obesity, chronic obstructive pulmonary disease, advanced age, hypertension, immunosuppression, and chronic kidney disease (CKD); we observed that obesity mediates 49.5% of the effect of diabetes on COVID-19 lethality. Early-onset diabetes conferred an increased risk of hospitalization and obesity conferred an increased risk for intensive care unit admission and intubation. Our predictive score for COVID-19 lethality included age ≥ 65 years, diabetes, early-onset diabetes, obesity, age < 40 years, CKD, hypertension, and immunosuppression and significantly discriminates lethal from non-lethal COVID-19 cases (C-statistic = 0.823). Conclusions: Here, we propose a mechanistic approach to evaluate the risk for complications and lethality attributable to COVID-19, considering the effect of obesity and diabetes in Mexico. Our score offers a clinical tool for quick determination of high-risk susceptibility patients in a first-contact scenario.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469
Simonnet, A., Chetboun, M., Poissy, J., Raverdy, V., Noulette, J., Duhamel, A., Labreuche, J., Mathieu, D., Pattou, F., Jourdain, M., et al. (2020) · Obesity · doi:10.1002/oby.22831 · Cited by 2,079
Cytokine release syndrome in severe COVID-19
Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912
CDC COVID-19 Response Team, CDC COVID-19 Response Team, Chow, N., Fleming-Dutra, K., Gierke, R., Hall, A., Hughes, M., Pilishvili, T., Ritchey, M., Roguski, K., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6913e2 · Cited by 1,404
Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., & Garg, R. (2005) · Circulation · doi:10.1161/01.cir.0000158483.13093.9d · Cited by 1,263
Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission
Lighter, J., Phillips, M., Hochman, S., Sterling, S., Johnson, D., Francois, F., & Stachel, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa415 · Cited by 1,225
Increased Risk of Common Infections in Patients with Type 1 and Type 2 Diabetes Mellitus
Muller, L. M. A. J., Gorter, K. J., Hak, E., Goudzwaard, W. L., Schellevis, F. G., Hoepelman, A. I. M., & Rutten, G. E. H. M. (2005) · Clinical Infectious Diseases · doi:10.1086/431587 · Cited by 1,023
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
Singh, A. K., Gupta, R., Ghosh, A., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.004 · Cited by 893
The effect of obesity on lung function
Dixon, A. E., & Peters, U. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1506331 · Cited by 889
Yang, J. K., Feng, Y., Yuan, M. Y., Yuan, S. Y., Fu, H. J., Wu, B. Y., Sun, G. Z., Yang, G. R., Zhang, X. L., Wang, L., et al. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01861.x · Cited by 794
Van Kerkhove, M. D., Vandemaele, K. A. H., Shinde, V., Jaramillo-Gutierrez, G., Koukounari, A., Donnelly, C. A., Carlino, L. O., Owen, R., Paterson, B., Pelletier, L., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001053 · Cited by 706
Obesity and its implications for covid-19 mortality
Dietz, W., & Santos‐Burgoa, C. (2020) · Obesity · doi:10.1002/oby.22818 · Cited by 687
Circulating Mononuclear Cells in the Obese Are in a Proinflammatory State
Ghanim, H., Aljada, A., Hofmeyer, D., Syed, T., Mohanty, P., & Dandona, P. (2004) · Circulation · doi:10.1161/01.cir.0000142055.53122.fa · Cited by 611
Obesity is associated with impaired immune response to influenza vaccination in humans
Sheridan, P. A., Paich, H. A., Handy, J., Karlsson, E. A., Hudgens, M. G., Sammon, A. B., Holland, L. A., Weir, S., Noah, T. L., & Beck, M. A. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.208 · Cited by 598
Obesity and the risk and outcome of infection
Huttunen, R., & Syrjänen, J. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.62 · Cited by 594
Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico
The SIGMA Type 2 Diabetes Consortium (2014) · Nature · doi:10.1038/nature12828 · Cited by 507
Young-onset type 2 diabetes mellitus — implications for morbidity and mortality
Magliano, D. J., Sacre, J. W., Harding, J. L., Gregg, E. W., Zimmet, P. Z., & Shaw, J. E. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0334-z · Cited by 483
Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic
Luzi, L., & Radaelli, M. G. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01522-8 · Cited by 382
Hodgson, K., Morris, J., Bridson, T., Govan, B., Rush, C., & Ketheesan, N. (2015) · Immunology · doi:10.1111/imm.12394 · Cited by 367
Liang, W.-H., Guan, W.-J., Li, C.-C., Li, Y.-M., Liang, H.-R., Zhao, Y., Liu, X.-Q., Sang, L., Chen, R.-C., Tang, C.-L., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00562-2020 · Cited by 303
Rao, S., Lau, A., & So, H.-C. (2020) · Diabetes Care · doi:10.2337/dc20-0643 · Cited by 268
COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology
Puig-Domingo, M., Marazuela, M., & Giustina, A. (2020) · Endocrine · doi:10.1007/s12020-020-02294-5 · Cited by 248
Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality
Fernandez, C., Rysä, J., Almgren, P., Nilsson, J., Engström, G., Orho‐Melander, M., Ruskoaho, H., & Melander, O. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12783 · Cited by 211
Two Things about COVID-19 Might Need AttentionPreprint
Jia, X., Yin, C., Lu, S., Chen, Y., Liu, Q., Bai, J., & Lu, Y. (2020) · Preprints.org · doi:10.20944/preprints202002.0315.v1 · Cited by 142
Epidemiology of diabetes mellitus in Mexico
Bello‐Chavolla, O. Y., Rojas, R., Aguilar-Salinas, C. A., & Hernández‐Ávila, M. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nuw030 · Cited by 123
Self-citationHypertension and Diabetes Delay the Viral Clearance in COVID-19 PatientsPreprint
Chen, X., Hu, W., Ling, J., Mo, P., Zhang, Y., Jiang, Q., Ma, Z., Cao, Q., Deng, L., Song, S., et al. (2020) · medRxiv · doi:10.1101/2020.03.22.20040774 · Cited by 120
Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity
Klonoff, D. C., & Umpierrez, G. E. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154224 · Cited by 105
Shamah‐Levy, T., Campos‐Nonato, I., Cuevas‐Nasú, L., Hernández-Barrera, L., Morales‐Ruán, M. D. C., Rivera, J. Á., & Barquera, S. (2019) · Salud Pública de México · doi:10.21149/10585 · Cited by 86
Familial Early-Onset Type 2 Diabetes in Chinese Patients
Ng, M. C. Y., Lee, S., Ko, G. T. C., Li, J. K. Y., So, W., Hashim, Y., Barnett, A. H., Mackay, I. R., Critchley, J., Cockram, C. S., et al. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.663 · Cited by 83
Bacterial pneumonia: comparison between diabetics and non-diabetics
Akbar, D. H. (2001) · Acta Diabetologica · doi:10.1007/s005920170017 · Cited by 78
Does Coronavirus Disease 2019 Disprove the Obesity Paradox in Acute Respiratory Distress Syndrome?
José, R. J. P., & Manuel, A. R. (2020) · Obesity · doi:10.1002/oby.22835 · Cited by 70
Prevalence and characteristics of early-onset type 2 diabetes in Mexico
Aguilar-Salinas, C. A., Rojas, R., Gomez-Perez, F. J., Garcı́a, E., Valles, V., Ríos-Torres, J. M., Franco, A., Oláiz, G., Sepúlveda, J., & Rull, J. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01314-1 · Cited by 68
Self-citationArellano‐Campos, O., Gómez‐Velasco, D., Bello‐Chavolla, O. Y., Cruz‐Bautista, I., Melgarejo-Hernández, M. A., Muñóz-Hernández, L. L., Guillén-Pineda, L. E., Garduño‐García, J. D. J., Alvirde, U., Ono‐Yoshikawa, Y., et al. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0361-8 · Cited by 61
Self-citationJiménez-Corona, A., Rojas, R., Gómez-Pérez, F. J., & Aguilar-Salinas, C. A. (2010) · Salud Pública de México · doi:10.1590/s0036-36342010000700006 · Cited by 36
Self-citationMediation analysis with causally ordered mediators using Cox proportional hazards model
Cho, S., & Huang, Y. (2018) · Statistics in Medicine · doi:10.1002/sim.8058 · Cited by 33
Bello‐Chavolla, O. Y., Bahena-López, J. P., Garciadiego-Fossas, P., Volkow, P., Garcia‐Horton, A., Velázquez-Acosta, C., & Vilar‐Compte, D. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4275-1 · Cited by 31
Self-citationNieto, C., Tolentino‐Mayo, L., Monterrubio‐Flores, E., Medina, C., Patiño, S. R., Aguirre‐Hernández, R., & Barquera, S. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.07.016 · Cited by 29
SARS-CoV-2 shedding and infectivity – Authors' reply
Zhou, F., Fan, G., Liu, Z., & Cao, B. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30869-2 · Cited by 28
Almeda‐Valdés, P., Gómez‐Velasco, D., Arellano‐Campos, O., Bello‐Chavolla, O. Y., Sevilla-González, M. D. R., Viveros-Ruiz, T. L., Martagón, A. J., Bautista, C. J., Muñóz-Hernández, L. L., Cruz‐Bautista, I., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0677 · Cited by 26
Self-citationCampos‐Nonato, I., Ramírez-Villalobos, D., Flores-Coria, A., Valdez, A., & Monterrubio‐Flores, E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230752 · Cited by 22
Cited by
Wynants, L., Van Calster, B., Bonten, M. M., Collins, G. S., Debray, T. P., De Vos, M., Haller, M. C., Heinze, G., Moons, K. G., Riley, R. D., et al. (2020) · doi:10.1101/2020.03.24.20041020 · Cited by 3,070
Popkin, B. M., Du, S., Green, W. D., Beck, M. A., Algaith, T., Herbst, C. H., Alsukait, R. F., Alluhidan, M., Alazemi, N., & Shekar, M. (2020) · Obesity Reviews · doi:10.1111/obr.13128 · Cited by 1,150
Booth, A., Reed, A. B., Ponzo, S., Yassaee, A., Aral, M., Plans, D., Labrique, A., & Mohan, D. (2021) · PLOS ONE · doi:10.1371/journal.pone.0247461 · Cited by 551
Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
Stefan, N., Birkenfeld, A. L., & Schulze, M. B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00462-1 · Cited by 452
Romero Starke, K., Reissig, D., Petereit-Haack, G., Schmauder, S., Nienhaus, A., & Seidler, A. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-006434 · Cited by 373
Metadata
- Authors
- Bello-Chavolla, O. Y., Bahena-López, J. P., Antonio-Villa, N. E., Vargas-Vázquez, A., González-Díaz, A., Márquez-Salinas, A., Fermín-Martínez, C. A., Naveja, J. J., & Aguilar-Salinas, C. A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2020-05-31
- Volume
- 105
- Issue
- 8
- Pages
- 2752-2761
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W3029548865
- Cited by
- 493
- References
- 42
- FWCI
- 13.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.